Patent Assignment
Reel/Frame 040169/0990
Change of Name
Recorded: 2016-09-28
Pages: 4
Assignor
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Executed: 2016-04-15
Assignee
APTEVO RESEARCH AND DEVELOPMENT LLC
2401 4TH AVENUE, SUITE 1050, SEATTLE, WASHINGTON, 98121
Covered Property
(1)
Cell Line-Based Redirected T-Cell Cytotoxicity Assay
Application:
15/126,922 →
Publication:
US 2017/0089885
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 22, 2016
From: BLANKENSHIP, JOHN; LOWE, RICHARD; SEWELL, ELAINE
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 039835/0245 →
Security Interest
Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Release of Security Interest
Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →